A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
D000368:Aged; D002986:Clinical Trials as Topic; D004088:Dihydroergotoxine / Q000009:adverse effects / Q000627:therapeutic use*; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy*; D010919:Placebos
D010919:Placebos; D004088:Dihydroergotoxine; D004877:Ergoloid Mesylates